Sunesis Pharmaceuticals Reports Third Quarter 2015 Financial Results And Recent Highlights
SOUTH SAN FRANCISCO, Calif. -- Sunesis Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2015. Loss from operations for the three and nine months ended September ... Read News
Relapsed/refractory (RR) Chronic Lymphocytic leukemia (CLL ...
A multicenter, open-label, phase 1b/2 study (PCYC-1108, N=30) evaluating the safety and efficacy of ibrutinib 420 mg orally once daily in combination with bendamustine and rituximab in patients with RR ... Fetch Doc
Dose Escalation Of Lenalidomide In Relapsed Or Refractory ...
We report results of a phase I dose-escalation trial of lenalidomide in relapsed or refractory acute leukemia. Patients and Methods Thirty-one adults with acute myeloid leukemia (AML) and four adults with acute lymphoblastic leukemia (ALL) were enrolled. ... Access Full Source
FLUDARABINE AND CYTARABINE FOR RECURRENT OR REFRACTORY ...
FLUDARABINE AND CYTARABINE. FOR RECURRENT OR REFRACTORY LEUKEMIA (AML, ALL, CML in blast crisis) Contact Physician:_____ Pager: _____ ... Fetch Here
Allogeneic Blood Stem Cell Transplantation For Refractory ...
Allogeneic Blood Stem Cell Transplantation for Refractory Leukemia and Lymphoma: Potential Advantage of Blood Over Marrow Allografts ... Get Doc
Bisantrene In Relapsed And Refractory Acute Myelogenous Leukemia
BISANTRENE IN RELAPSED AND REFRACTORY AML 219 Table 2 Results Neither hypotension nor anaphylactoid reactions were observed and no cardiovascular dysfunction ... Fetch Document
High-Dose Cytosine Arabinoside Therapy For Refractory Leukemia
HIGH-DOSE ARA-C FOR REFRACTORY LEUKEMIA 363 Table 2. Frequency of Systemic Effects of Hig h-Dose Cytosine Arabinoside Dose Level (g/ sq m q. 12 hr x No. Doses) ... Retrieve Doc
Treatment Of refractory And Relapsed Acute Myelogenous leukemia
Treatment of refractory & relapsed AML www.future-drugs.com 289 Summary of allogeneic transplantation Given the length of time needed to coordinate an allogeneic trans- ... Read Document
Novel Treatment Approaches To Relapsed/Refractory CLL
Panelists discuss treatment options and challenges for patients with relapsed or refractory chronic lymphocytic leukemia. ... View Video
Difference Between Sepsis Infection And Septic Shock
What is the difference between sepsis and septic shock? Find out what sepsis is, how it differs from septic shock, and what causes septic shock after surgery or infection. ... Read Article
Targeting Vascular Endothelial Growth Factor For Relapsed And ...
Refractory Adult Acute Myelogenous Leukemias: Therapy with Sequential 1- -D-Arabinofuranosylcytosine, Mitoxantrone, One patient with primary refractory leukemia suffered overwhelming tumor lysis with multiorgan failure on day 3 of ara-C and mitoxantrone and did not receive bevaci- ... Read More
Cellectis: UCART19: First In Man Proof Of Concept To Be Presented At 2015 ASH Annual Meeting
Regulatory News: ... Read News
Sunesis Pharmaceuticals Announces Presentations At ASH Annual Meeting
SOUTH SAN FRANCISCO, Calif. -- Sunesis Pharmaceuticals, Inc. today announced one oral presentation and two poster presentations at the 57th American Society of Hematology Annual Meeting to be held December ... Read News
Microsoft PowerPoint - ENMD.Leukemia Poster ASH2010 (FINAL).ppt
A Phase I Study of ENMD-2076 in Patients with Relapsed or Refractory Leukemia KWL Yee, HWT Chen, J Brandwein, S Chow, D Sanfelice, D Hedley, V Gupta, A Schimmer, CF Sidor, G Fletcher, J Arnott, M Bray, MD Minden, A Schuh ... Fetch Document
Refractory chronic lymphocytic leukemia – new therapeutic strategies Andrea Schnaiter and Stephan Stilgenbauer * University of Ulm, Ulm, Germany Correspondence to: Dr. Stephan Stilgenbauer, e-mail: stephan.stilgenbauer@uniklinik-ulm.de ... Read Content
Idarubicin In Refractory Acute Leukemia - Karger Publishers
We have treated 10 acute leukemia patients with idarubicin. All patients had been intensively pretreated. 1 patient had acute lymphatic leukemia in first relapse, which was refractory to ... Read Full Source
Relapsed And Refractory Hodgkin Lymphoma
Relapsed and Refractory Hodgkin Lymphoma Lymphoma Overview Lymphoma is a cancer of the white blood cells, namely lymphocytes, which constitute the lymphatic system. ... Fetch Document
Juvenile Myelomonocytic leukemia - Wikipedia, The Free ...
Juvenile myelomonocytic leukemia (JMML) is a serious chronic leukemia (cancer of the blood) that affects children mostly aged 4 and younger. Refractory anemia with excess of blasts; Chromosome 5q deletion syndrome; Sideroblastic anemia; ... Read Article
BRAF Inhibition In Refractory Hairy-Cell Leukemia
The new engl and journal of medicine 2038 n engl j med 366;21 nejm.org may 24, 2012 BRAF Inhibition in Refractory Hairy-Cell Leukemia To the Editor: Hairy-cell leukemia (HCL) is a ... Retrieve Full Source
Prostate Cancer Treatment, Longevity And LIfe Expectancy
Prostate cancer treatment is complex. Knowing which treatment will give the greatest life expectancy is a difficult decisions. Doctors and patients much choose among prostatectomy, radiotherapy, watchful waiting, hormone therapy and other treatments. ... Read Article
Leukemia - E-Science Central
12-O-Tetradecanoylphorbol-13-Acetate for Refractory Secondary Acute Myeloid Leukemia Quande Lin, Baijun Fang, Yufu Li, Jianwei Du and Yongping Song* ... View Document
Leukemoid Reaction - Wikipedia, The Free Encyclopedia
However, leukemoid reactions can resemble more serious conditions such as chronic myelogenous leukemia (CML), Refractory anemia; Refractory anemia with excess of blasts; Chromosome 5q deletion syndrome; Sideroblastic anemia; Paroxysmal nocturnal hemoglobinuria; ... Read Article
Www.fda.gov
In relapsed or refractory acute promyelocytic leukemia (APL) Your Goal: Molecular Remission TRISENOX (arsenic trioxide) is indicated for induction ... Read Content
Successful Induction Therapy With Decitabine In refractory ...
LETTERS TO THE EDITOR Successful induction therapy with decitabine in refractory childhood acute lymphoblastic leukemia Leukemia (2009) 23, 1342–1343; doi:10.1038/leu.2009.58; ... View Full Source
Treatment Of Patients With Refractory Myelogenous Leukemia
T. S. Herman et al.: Treatment of Patients with Refractory Myelogenous Leukemia with BCOMM 75 Discussion We were able to induce a CR in five of ten patients ... Read Full Source
Blinatumomab Shown To Be Beneficial In Relapsed/refractory B ...
Visit http://www.ecancer.org for more. Prof Topp talks to ecancertv at ASCO 2014 about the results of a multicenter phase 2 study of the BiTE antibody blinatumomab in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia. The use of blinatumomab is an antibody ... View Video
Refractory Anemia With Excess Of Blasts - Wikipedia, The Free ...
Refractory anemia with excess of blasts (RAEB) is a type of myelodysplastic syndrome [1] with a marrow blast percentage of 5% to 19%. [2] In MeSH, "Smoldering leukemia" is classified under RAEB. ... Read Article
Intermediate-Dose Cytarabine In The Treatment Of Relapsed Or ...
Intermediate-Dose Cytarabine in the Treatment of Relapsed or Refractory Leukemias 1. L. Harousseau and N. Milpied High-dose cytarabine (HD ARA-C) has ... View This Document
No comments:
Post a Comment